Channel Medsystems, Inc.
$194.3K 521 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Sequence LifeScience, Inc
Sequence LifeScience, Inc reported $194,500.00 across General Payments, Research, and Ownership to 64 physicians and teaching hospitals across 64 transactions.
- $194.5K Below-median payer
- All-tracks total
- 64 Below-median volume
- Transactions
- 64 Below-median reach
- Recipients
- #1008
- of 1,925 companies
Sequence LifeScience, Inc reported $194,500.00 across all CMS Open Payments tracks (General + Research + Ownership) to 64 physicians and teaching hospitals in Program Year 2024 - ranking #1008 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $194,500.00, averaging $3.0K per recipient.
Sequence LifeScience, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sequence-lifescience-inc Sequence LifeScience, Inc
$194.5K · #1008/1,925 · 0.0% industry · PY2024
- TOT $194.5K
- RANK #1008
- SHARE 0.0%
- TXN 64
- RCP 64
- CAT 1
- GEN $194.5K
- TOP1 84.6%
- PY 2024
Volume peers
Nearest volume peer: Channel Medsystems, Inc. ($194.3K)
Sequence LifeScience, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Sequence LifeScience, Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Sequence LifeScience, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Consulting Fee" leads the 1-category general-payment breakdown below at $194.5K (100.0% of General Payments, 64 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Sequence LifeScience, Inc made 1 types of general payments. "Consulting Fee" is the largest category at $194.5K, 100.0% of General Payments.
How Sequence LifeScience, Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $194.5K | 64 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $194,500.00 (100.0%) of $194,500.00 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sequence LifeScience, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Michael Bauer
$164,500.00 across 52 reported transactions
- 2
Walter Strash
$30,000.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Sequence LifeScience, Inc ranks #1008 of 1,925 by total payments (bottom 48% by spend) but is notably more concentrated than that alone would suggest -- #211 of 1,838 by HHI (top 11% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Preceptis Medical, Inc. : $60.6K total payments, HHI 7566
- UCB Biosciences Inc. : $16.7K total payments, HHI 7541
- Siesta Medical, Inc. : $19.1K total payments, HHI 7498
- Innovative Medical Products, Inc. : $22.8K total payments, HHI 7434
- Teleflex Medical Incorporated : $268.8K total payments, HHI 7395
- Aesculap Biologics, LLC : $5.2K total payments, HHI 7394
- Sequence LifeScience, Inc (this company) : $194.5K total payments, HHI 7391
- Elekta, Inc. : $3.2M total payments, HHI 7371
- Nanovis LLC : $47.0K total payments, HHI 7351
- Atrility Medical, Inc. : $712.50 total payments, HHI 7341
- Dimension Inx Corp : $1.2K total payments, HHI 7329
- Maillefer Instruments Holding Sarl : $369.3K total payments, HHI 7308
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sequence LifeScience, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sequence LifeScience, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sequence LifeScience, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Medicem Inc.
$194.1K 94 recipients
Compare payment profiles
Pulpdent Corporation
$194.0K 159 recipients
Compare payment profiles
NanoFuse Biologics LLC
$193.9K 0 recipients
Compare payment profiles
Carestream Health, Inc.
$193.5K 21 recipients
Compare payment profiles
Vapotherm Inc
$195.6K 375 recipients
Compare payment profiles
Put this to use
Sequence LifeScience, Inc ranks #1008 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Sequence LifeScience, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.